medigraphic.com
Colegio de Medicina Interna de México.

2024, Number 5

Next >>

Med Int Mex 2024; 40 (5)

Dengue epidemiological trends in Latin America: 2019-2024

Rodríguez ASE, Méndez MS, Guerrero BS, Ayón AJ, García FMA, Santos LG

Language: Spanish
References: 26
Page: 287-294
PDF size: 549.69 Kb.


ABSTRACT

Objective: To describe the epidemiological behavior of dengue and its serotypes in Mexico and Latin America.
Materials and Methods: A descriptive analysis was conducted using data from the Information Platform for Health of the Americas (PLISA) and national and international epidemiological bulletins from January 2019 to January 2024. Confirmed, severe and non-severe cases, cases with and without warning signs, fatal cases, simultaneous circulation, serotypes, and mortality rates were identified.
Results: A total of 13,967,156 dengue cases were registered in Latin America during the study period. Of these, 42% were laboratory-confirmed. There were 7,600,985 non-severe cases, 47,700 severe cases, and 6278 fatal cases. The countries with the highest number of severe cases were Brazil, Honduras, Colombia, and Mexico. The most frequent serotypes were 1 and 2. An increase in the simultaneous circulation of the four serotypes was observed, as well as an increase in serotype 3 in Mexico.
Conclusiones: In Latin America, the number of dengue cases increased, but not the severity, mortality or lethality. The simultaneous circulation of multiple serotypes poses a challenge for prevention and control efforts.


REFERENCES

  1. Bhatt P, Sabeena SP, Varma M, et al. Current understandingof the pathogenesis of dengue virus infection. CurrMicrobiol 2021; 78 (1): 17-32. https://doi.org/10.1007/s00284-020-02284-w

  2. Roy SK, Bhattacharjee S. Dengue virus: epidemiology,biology, and disease aetiology. Can J Microbiol 2021; 67(10): 687-702. https://doi.org/10.1139/cjm-2020-0572

  3. Martins ABS, Correia FGS, Cavalcanti LP de G, et al. Denguein northeastern Brazil: a spatial and temporal perspective.Rev Soc Bras Med Trop 2020; 53: e20200435. https://doi.org/10.1590/0037-8682-0435-2020

  4. Vezzani D, Cetraro H, Chopa FS. Vigilancia del vector deldengue en el límite de su distribución. Una experienciacolaborativa entre los ámbitos científico, municipal yciudadano. Med B Aires 2022; 82 (4): 505-12.

  5. Britos M. Implicancia del cambio climático en la aparicióndel riesgo de transmisión de dengue por Aedes aegypti ysu adaptación a las condiciones ambientales locales. Unarevisión sistemática. Rev Soc Científica Parag 2022; 27(1): 120-37. https://doi.org/10.32480/rscp.2022.27.1.120

  6. Arbo Antonio, Sanabria Gabriela, Martínez Celia. Influenciadel cambio climático en las enfermedades transmitidas porvectores. Rev Inst Med Trop 2022; 17 (2): 23-36.

  7. Lessa CLS, Hodel KVS, Gonçalves M de S, et al. Dengueas a disease threatening global health: A narrativereview focusing on Latin America and Brazil Trop MedInfect Dis 2023; 8 (5): 241. https://doi.org/10.18004/imt/2022.17.2.4

  8. CDC. Centers for Disease Control and Prevention. 2019.Cuadro clínico del dengue.

  9. Harapan H, Michie A, Sasmono RT, et al. Dengue: A minireview.Viruses 2020; 12 (8): 829. https://doi.org/10.3390/v12080829

  10. Pandey A, Verma R, Jain A, et al. Correlation of serotypespecificstrain in patients with dengue virus infection withneurological manifestations and its outcome. Neurol Sci2022; 43 (3): 1939-46. https://doi.org/10.1007/s10072-021-05477-8

  11. Guzmán-Terán C, Calderón-Rangel A, Rodriguez-MoralesA, et al. Venezuelan equine encephalitis virus: the problemis not over for tropical America. Ann Clin MicrobiolAntimicrob 2020. https://doi.org/10.1186/s12941-020-00360-4

  12. Tayal, A., Kabra, SK y Lodha, R. Manejo del dengue: unarevisión actualizada. Indian J Pediatr 2023; 90: 168-177.https://doi.org/10.1007/s12098-022-04394-8

  13. World Health Organization. Dengue guidelines for diagnosis,treatment, prevention and control: new edition.World Health Organization 2009. https://iris.who.int/handle/10665/44188

  14. Editorial. Significado de mortalidad. En: Significados.com.https://www.significados.com/mortalidad/

  15. OPS.org Alerta Epidemiológica - Aumento de casos de dengueen América Central y el Caribe OPS/OMS|OrganizaciónPanamericana de la Salud. https://www.paho.org/es/documentos/alerta-epidemiologica-aumento-casos-dengueamerica-central-caribe-15-septiembre-2023

  16. OPS.org Organización Panamericana de la Salud. https://www.paho.org/es/documentos/actualizacion-epidemiologica-dengue-chikunguna-zika-25-enero-2023

  17. Santos LL, de Aquino EC, Fernandes SM, Ternes YMF,Feres VC de R. Dengue, chikungunya, and Zika virus infectionsin Latin America and the Caribbean: a systematicreview. Rev Panam Salud Pública 2023; 47: 34. https://doi.org/10.26633/RPSP.2023.34

  18. OPS.org Organización Panamericana de la Salud .https://www.paho.org/es/documentos/actualizacion-epidemiologica-dengue-7-febrero-2020

  19. Organización Panamericana de la Salud. Actualizaciónepidemiológica dengue, chikunguña y Zika.

  20. Warnes CM, Santacruz-Sanmartín E, Bustos Carrillo F, etal. Surveillance and epidemiology of dengue in Medellín,Colombia from 2009 to 2017. Am J Trop Med Hyg 2021;104 (5): 1719-28. https://doi.org/10.4269/ajtmh.19-0728

  21. Gutierrez-Barbosa H, Medina-Moreno S, Zapata JC, et al.Dengue infections in Colombia: Epidemiological trends ofa hyperendemic country. Trop Med Infect Dis 2020; 5 (4):156. https://doi.org/10.3390/tropicalmed5040156

  22. De Jesus JG, Dutra KR, Sales FC da S, et al. Genomic detectionof a virus lineage replacement event of denguevirus serotype 2 in Brazil, 2019. Mem Inst Oswaldo Cruz2020; 115: e190423. https://doi.org/10.1590/0074-02760190423

  23. Kariyawasam R, Lachman M, Mansuri S, Chakrabarti S,Boggild AK. A dengue vaccine whirlwind update. Ther AdvInfect Dis 2023; 10. doi:10.1177/20499361231167274

  24. Forrat R, Dayan GH, Diaz Granados CA, Bonaparte M, etal. Analysis of hospitalized and severe dengue cases overthe 6 years of follow-up of the tetravalent dengue vaccine(CYD-TDV) efficacy trials in Asia and Latin America. Clin InfectDis 2021; 73 (6): 1003-1012. https://doi.org/10.1093/cid/ciab288

  25. Lovera D, Martínez-Cuellar C, Galeano F, et al. Clinical manifestationsof primary and secondary dengue in Paraguayand its relation to virus serotype. J Infect Dev Ctries 2019;13 (12): 1127-34. https://doi.org/10.3855/jidc.11584

  26. Nunes PCG, Daumas RP, Sánchez-Arcila JC, et al. 30 years offatal dengue cases in Brazil: a review. BMC Public Health 2019;19 (1): 329. https://doi.org/10.1186/s12889-019-6641-4




2020     |     www.medigraphic.com